RankAlpha logo
Back to Rankings

LGVN

LongeveronF
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
View Chart
+
Peers tracked
8
U.S. public peers
Grade Position
Below peers
vs peer average
LGVN vs peer average
34/100
LGVN vs. peer average (F vs. D)
Grade spread
B 2 · F 4
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

MRKR is the first available peer comparator.

Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $23.68M

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerMRKRMarker Therapeutics
LGVN
Longeveron
MRKR
Marker Therapeutics
Grade
F
B
Momentum
12
74
Value
41
41
Sentiment
-
-
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Defensive
Constructive
Open Side-by-Side ComparisonCompare all

Grade position vs MRKR

LGVN / MRKR
Grade Position
Below peers
LGVN vs. peer average (F vs. D)
34/100
Momentum
12
MRKR
Value
41
LGVN
Sentiment
-
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs LGVN
1
MRKR
Marker Therapeutics Inc Common
B
80/100
-3
2
BCTX
BriaCell Therapeutics Corp Common
F
20/100
Even
3
TXMD
TherapeuticsMD Inc Common
B
80/100
-3
4
ZYBT
Zhengye Biotechnology Holding Ltd Class A Common
N/A
-
-
5
PTN
Palatin Technologies Inc Common
F
20/100
Even
MRKR is the first peer returned for this comparison set.